HA35 (35 kDa hyaluronan fragment)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for HA35 (35 kDa hyaluronan fragment), covering 2024-05-21 to 2024-05-21. Get the full timeline:
Most recent: Clinical Trial Update: 35 kDa Hyaluronan Fragment (HA35) Reduces Chronic Inflammation of Skin [NA]